Lessons Learned from the Randomized Controlled TOmosynthesis plus SYnthesized MAmmography (TOSYMA) Trial
Cindy S. Lee, Linda Moy
Radiology. 2023 Feb;306(2):e222178. doi: 10.1148/radiol.222178. Epub 2022 Oct 4.
Erste Ergebnisse zur multizentrischen, randomisierten, kontrollierten Brustkrebs-Diagnostikstudie ToSyMa
W. Heindel , S. Weigel
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2022; 18(02): 125-126; DOI: 10.1055/a-1826-6228
Surrogate endpoints in breast cancer screening trials - Authors' Reply
W. Heindel, S. Weigel, H.W. Hense
Lancet Oncol. 2022 Aug;23(8):e361. doi: 10.1016/S1470-2045(22)00396-5.
Digital breast tomosynthesis plus synthesized mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomized, controlled, superiority trial
W. Heindel*, S. Weigel*, J. Gerß, H.W. Hense, A. Sommer, M. Krischke, L. Kerschke, for the TOSYMA Screening Trial Study Group *WH and SW contributed equally to this work.
Lancet Oncol. 2022 May;23(5):601-611. doi: 10.1016/S1470-2045(22)00194-2. Epub 2022 Apr 12.
Das Mammografie-Screening: Sollte es abgeschafft werden?
K. Bock, G. Hecht, W. Heindel, S. Heywang-Köbrunner, K. Siegmann-Luz
Geburtshilfe Frauenheilkd 2021; 81(09): 1011-1013 DOI: 10.1055/a-1372-7531
Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer
P. Backhaus, M. C. Burg, W. Roll, F. Büther, H.J. Breyholz, S. Weigel, W. Heindel, M. Pixberg, P. Barth, J. Tio, M. Schäfers
Radiology. 2022 Jan;302(1):39-47. doi: 10.1148/radiol.2021204677. Epub 2021 Oct 12.